290 related articles for article (PubMed ID: 18420938)
21. 11beta-hydroxysteroid dehydrogenase type 1 inhibitors as promising therapeutic drugs for diabetes: status and development.
Ge R; Huang Y; Liang G; Li X
Curr Med Chem; 2010; 17(5):412-22. PubMed ID: 20015040
[TBL] [Abstract][Full Text] [Related]
22. Characterisation of the prereceptor regulation of glucocorticoids in the anterior segment of the rabbit eye.
Onyimba CU; Vijapurapu N; Curnow SJ; Khosla P; Stewart PM; Murray PI; Walker EA; Rauz S
J Endocrinol; 2006 Aug; 190(2):483-93. PubMed ID: 16899581
[TBL] [Abstract][Full Text] [Related]
23. Tissue Glucocorticoid Metabolism in Adrenal Insufficiency: A Prospective Study of Dual-release Hydrocortisone Therapy.
Dineen RA; Martin-Grace J; Ahmed KMS; Taylor AE; Shaheen F; Schiffer L; Gilligan LC; Lavery GG; Frizelle I; Gunness A; Garrahy A; Hannon AM; Methlie P; Eystein SH; Stewart PM; Tomlinson JW; Hawley JM; Keevil BG; O'Reilly MW; Smith D; McDermott J; Healy ML; Agha A; Pazderska A; Gibney J; Behan LA; Thompson CJ; Arlt W; Sherlock M
J Clin Endocrinol Metab; 2023 Nov; 108(12):3178-3189. PubMed ID: 37339332
[TBL] [Abstract][Full Text] [Related]
24. In vivo evaluation of 11beta-hydroxysteroid dehydrogenase activity in the rabbit eye.
Anderson S; Carreiro S; Quenzer T; Gale D; Xiang C; Gukasyan H; Lafontaine J; Cheng H; Krauss A; Prasanna G
J Ocul Pharmacol Ther; 2009 Jun; 25(3):215-22. PubMed ID: 19456256
[TBL] [Abstract][Full Text] [Related]
25. The rise in expression and activity of 11β-HSD1 in human mesenchymal progenitor cells induces adipogenesis through increased local cortisol synthesis.
Blaschke M; Koepp R; Streit F; Beismann J; Manthey G; Seitz MT; Kragl A; Siggelkow H
J Steroid Biochem Mol Biol; 2021 Jun; 210():105850. PubMed ID: 33639236
[TBL] [Abstract][Full Text] [Related]
26. Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning.
Walker BR
Proc Nutr Soc; 2007 Feb; 66(1):1-8. PubMed ID: 17343766
[TBL] [Abstract][Full Text] [Related]
27. Tissue specific regulation of glucocorticoids in severe obesity and the response to significant weight loss following bariatric surgery (BARICORT).
Woods CP; Corrigan M; Gathercole L; Taylor A; Hughes B; Gaoatswe G; Manolopoulos K; Hogan AE; O'Connell J; Stewart PM; Tomlinson JW; O'Shea D; Sherlock M
J Clin Endocrinol Metab; 2015 Apr; 100(4):1434-44. PubMed ID: 25603461
[TBL] [Abstract][Full Text] [Related]
28. IL-13-induced changes in endogenous glucocorticoid metabolism in the lung regulate the proasthmatic response.
Josephson MB; Jiao J; Xu S; Hu A; Paranjape C; Grunstein JS; Grumbach Y; Nino G; Kreiger PA; McDonough J; Grunstein MM
Am J Physiol Lung Cell Mol Physiol; 2012 Sep; 303(5):L382-90. PubMed ID: 22773690
[TBL] [Abstract][Full Text] [Related]
29. 11beta-hydroxysteroid dehydrogenase type 1 and obesity.
Morton NM; Seckl JR
Front Horm Res; 2008; 36():146-164. PubMed ID: 18230901
[TBL] [Abstract][Full Text] [Related]
30. 11 Beta-hydroxysteroid dehydrogenase type 1 regulates synovitis, joint destruction, and systemic bone loss in chronic polyarthritis.
Hardy RS; Fenton C; Croft AP; Naylor AJ; Begum R; Desanti G; Buckley CD; Lavery G; Cooper MS; Raza K
J Autoimmun; 2018 Aug; 92():104-113. PubMed ID: 29891135
[TBL] [Abstract][Full Text] [Related]
31. Contribution of endogenous glucocorticoids and their intravascular metabolism by 11β-HSDs to postangioplasty neointimal proliferation in mice.
Iqbal J; Macdonald LJ; Low L; Seckl JR; Yau CW; Walker BR; Hadoke PW
Endocrinology; 2012 Dec; 153(12):5896-905. PubMed ID: 23125311
[TBL] [Abstract][Full Text] [Related]
32. The ratio of 11β-hydroxysteroid dehydrogenase 1/11β-hydroxysteroid dehydrogenase 2 predicts glucocorticoid response in nasal polyps.
Jiang L; Zhou M; Deng J; Sun Y; Zuo K; Zheng R; Shi J; Lai Y
Eur Arch Otorhinolaryngol; 2019 Jan; 276(1):131-137. PubMed ID: 30446829
[TBL] [Abstract][Full Text] [Related]
33. [Study on the relationship between 11β-hydroxysteroid dehydrogenase and glucocorticoid response in nasal polyps].
Jiang LJ; Zhou M; Deng J; Zuo KJ; Shi JB; Lai YY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Mar; 54(3):198-202. PubMed ID: 30909340
[No Abstract] [Full Text] [Related]
34. Characterisation of the cancer-associated glucocorticoid system: key role of 11β-hydroxysteroid dehydrogenase type 2.
Cirillo N; Morgan DJ; Pedicillo MC; Celentano A; Lo Muzio L; McCullough MJ; Prime SS
Br J Cancer; 2017 Sep; 117(7):984-993. PubMed ID: 28797028
[TBL] [Abstract][Full Text] [Related]
35. Quantification of 11β-hydroxysteroid dehydrogenase 1 kinetics and pharmacodynamic effects of inhibitors in brain using mass spectrometry imaging and stable-isotope tracers in mice.
Cobice DF; Livingstone DEW; McBride A; MacKay CL; Walker BR; Webster SP; Andrew R
Biochem Pharmacol; 2018 Feb; 148():88-99. PubMed ID: 29248595
[TBL] [Abstract][Full Text] [Related]
36. The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement.
Swords FM; Carroll PV; Kisalu J; Wood PJ; Taylor NF; Monson JP
Clin Endocrinol (Oxf); 2003 Nov; 59(5):613-20. PubMed ID: 14616886
[TBL] [Abstract][Full Text] [Related]
37. Carbonyl reduction of triadimefon by human and rodent 11β-hydroxysteroid dehydrogenase 1.
Meyer A; Vuorinen A; Zielinska AE; Da Cunha T; Strajhar P; Lavery GG; Schuster D; Odermatt A
Biochem Pharmacol; 2013 May; 85(9):1370-8. PubMed ID: 23419873
[TBL] [Abstract][Full Text] [Related]
38. Expression and functional consequences of 11beta-hydroxysteroid dehydrogenase activity in human bone.
Cooper MS; Walker EA; Bland R; Fraser WD; Hewison M; Stewart PM
Bone; 2000 Sep; 27(3):375-81. PubMed ID: 10962348
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 lowers intraocular pressure in patients with ocular hypertension.
Rauz S; Cheung CM; Wood PJ; Coca-Prados M; Walker EA; Murray PI; Stewart PM
QJM; 2003 Jul; 96(7):481-90. PubMed ID: 12881590
[TBL] [Abstract][Full Text] [Related]
40. Effect of AZD4017, a Selective 11β-HSD1 Inhibitor, on Bone Turnover Markers in Postmenopausal Osteopenia.
Abbas A; Schini M; Ainsworth G; Brown SR; Oughton J; Crowley RK; Cooper MS; Fairclough RJ; Eastell R; Stewart PM
J Clin Endocrinol Metab; 2022 Jun; 107(7):2026-2035. PubMed ID: 35275196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
